BIOMERICA INC (BMRA) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
56/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseBMRA / S&P -16.98% / 15.20% |
LoseBMRA / S&P -16.17% / 15.00% |
LoseBMRA / S&P -31.72% / 50.40% |
| 2026-Q10/3 |
LoseBMRA / S&P -15.87% / -4.33% |
LoseBMRA / S&P -23.81% / 11.30% |
LoseBMRA / S&P -57.75% / 27.70% |
| 2025-Q40/3 |
LoseBMRA / S&P -10.95% / 2.65% |
LoseBMRA / S&P -20.05% / 9.00% |
LoseBMRA / S&P -51.93% / 13.40% |
| 2025-Q30/3 |
LoseBMRA / S&P -10.44% / 8.12% |
LoseBMRA / S&P -11.31% / 4.61% |
LoseBMRA / S&P -63.82% / 13.45% |
| 2025-Q20/3 |
LoseBMRA / S&P -30.70% / 10.94% |
LoseBMRA / S&P -1.88% / 4.83% |
LoseBMRA / S&P -34.51% / 10.63% |
| 2025-Q13/3 |
WinBMRA / S&P 90.00% / -4.27% |
WinBMRA / S&P 5.05% / 4.98% |
WinBMRA / S&P 910.81% / 10.57% |
| 2024-Q41/3 |
LoseBMRA / S&P -9.09% / 2.41% |
LoseBMRA / S&P 1.40% / 5.25% |
WinBMRA / S&P 786.84% / 6.15% |
| 2024-Q31/3 |
LoseBMRA / S&P -25.00% / 5.89% |
LoseBMRA / S&P 1.72% / 5.89% |
WinBMRA / S&P 729.27% / 6.11% |
| 2024-Q21/3 |
LoseBMRA / S&P -46.99% / 4.28% |
LoseBMRA / S&P 1.41% / 5.38% |
WinBMRA / S&P 468.00% / 5.12% |
| 2024-Q10/3 |
LoseBMRA / S&P -33.60% / 10.56% |
LoseBMRA / S&P -43.30% / 5.71% |
LoseBMRA / S&P -31.48% / 5.59% |
| 2023-Q41/3 |
WinBMRA / S&P 45.35% / 11.69% |
LoseBMRA / S&P -65.80% / 6.81% |
LoseBMRA / S&P -11.63% / 7.78% |
| 2023-Q31/3 |
LoseBMRA / S&P -36.76% / -3.27% |
LoseBMRA / S&P -71.87% / 7.52% |
WinBMRA / S&P 2.50% / -5.03% |
| 2023-Q21/3 |
LoseBMRA / S&P -27.27% / 8.74% |
LoseBMRA / S&P -71.71% / 9.50% |
WinBMRA / S&P 38.89% / -8.57% |
| 2023-Q11/3 |
LoseBMRA / S&P -44.18% / 7.50% |
LoseBMRA / S&P -34.82% / 10.77% |
WinBMRA / S&P 54.29% / -15.69% |
| 2022-Q42/3 |
LoseBMRA / S&P -14.76% / 7.56% |
WinBMRA / S&P 51.82% / 11.88% |
WinBMRA / S&P -17.31% / -17.99% |
| 2022-Q32/3 |
WinBMRA / S&P 35.99% / -4.88% |
WinBMRA / S&P 163.00% / 13.47% |
LoseBMRA / S&P -31.03% / -1.41% |
| 2022-Q21/3 |
LoseBMRA / S&P -35.35% / -16.10% |
WinBMRA / S&P 162.10% / 13.71% |
LoseBMRA / S&P -41.94% / 11.04% |
| 2022-Q12/3 |
WinBMRA / S&P 14.91% / -4.60% |
WinBMRA / S&P 64.84% / 15.97% |
LoseBMRA / S&P -33.96% / 42.23% |
| 2021-Q41/3 |
LoseBMRA / S&P -13.56% / 11.03% |
WinBMRA / S&P 65.01% / 15.00% |
LoseBMRA / S&P 18.18% / 96.40% |
| 2021-Q32/3 |
WinBMRA / S&P 12.22% / 0.58% |
LoseBMRA / S&P 10.17% / 10.77% |
WinBMRA / S&P 70.59% / 69.42% |
| 2021-Q22/3 |
LoseBMRA / S&P -26.56% / 8.55% |
WinBMRA / S&P 7.58% / 6.58% |
WinBMRA / S&P 169.57% / 51.81% |
| 2021-Q13/3 |
WinBMRA / S&P 9.64% / 6.17% |
WinBMRA / S&P 72.81% / -1.06% |
WinBMRA / S&P 96.30% / 7.39% |
| 2020-Q42/3 |
LoseBMRA / S&P -28.14% / 12.15% |
WinBMRA / S&P 23.03% / -3.72% |
WinBMRA / S&P 76.00% / -33.42% |
| 2020-Q32/3 |
LoseBMRA / S&P -4.41% / 8.93% |
WinBMRA / S&P 29.69% / -2.04% |
WinBMRA / S&P 36.00% / -27.10% |
| 2020-Q22/3 |
LoseBMRA / S&P 1.40% / 20.54% |
WinBMRA / S&P 28.70% / -0.46% |
WinBMRA / S&P -8.00% / -27.11% |
| 2020-Q12/3 |
WinBMRA / S&P 136.75% / -19.60% |
LoseBMRA / S&P -0.61% / 3.47% |
WinBMRA / S&P 8.00% / -14.75% |
| 2019-Q41/3 |
LoseBMRA / S&P -7.08% / 9.07% |
LoseBMRA / S&P -1.18% / 5.36% |
WinBMRA / S&P 13.64% / 2.99% |
| 2019-Q32/3 |
WinBMRA / S&P 25.00% / 1.70% |
LoseBMRA / S&P -5.02% / 5.02% |
WinBMRA / S&P 25.00% / 0.21% |
| 2019-Q22/3 |
WinBMRA / S&P 4.42% / 4.30% |
LoseBMRA / S&P -6.54% / 6.64% |
WinBMRA / S&P 47.06% / 8.65% |
| 2019-Q12/3 |
WinBMRA / S&P 46.47% / 13.65% |
LoseBMRA / S&P -12.21% / 8.12% |
WinBMRA / S&P 92.31% / 14.29% |
| 2018-Q41/3 |
LoseBMRA / S&P -52.51% / -13.52% |
LoseBMRA / S&P -12.11% / 9.05% |
WinBMRA / S&P 69.23% / 18.23% |
| 2018-Q31/3 |
LoseBMRA / S&P -7.97% / 7.71% |
LoseBMRA / S&P -7.44% / 10.21% |
WinBMRA / S&P 66.67% / 19.06% |
| 2018-Q21/3 |
LoseBMRA / S&P -3.71% / 3.43% |
LoseBMRA / S&P -3.93% / 9.03% |
WinBMRA / S&P 54.55% / 14.46% |
| 2018-Q11/3 |
WinBMRA / S&P 8.02% / -0.76% |
LoseBMRA / S&P 3.79% / 7.68% |
LoseBMRA / S&P -43.48% / 12.46% |
| 2017-Q42/3 |
WinBMRA / S&P 34.53% / 6.64% |
WinBMRA / S&P 8.63% / 7.03% |
LoseBMRA / S&P -38.10% / 13.82% |
| 2017-Q32/3 |
WinBMRA / S&P 5.70% / 4.48% |
WinBMRA / S&P 10.70% / 5.68% |
LoseBMRA / S&P -40.00% / 17.57% |
| 2017-Q22/3 |
WinBMRA / S&P 20.09% / 3.09% |
WinBMRA / S&P 12.68% / 4.83% |
LoseBMRA / S&P -45.00% / 17.74% |
| 2017-Q12/3 |
LoseBMRA / S&P -4.78% / 6.07% |
WinBMRA / S&P 6.78% / 3.67% |
WinBMRA / S&P 6629298651489370112.00% / 13.32% |
| 2016-Q41/3 |
LoseBMRA / S&P -11.88% / 3.82% |
WinBMRA / S&P 5.41% / 2.09% |
LoseBMRA / S&P BMRA unavailable / 7.05% |
| 2016-Q33/3 |
WinBMRA / S&P 74.00% / 3.85% |
WinBMRA / S&P 0.92% / 0.20% |
WinBMRA / S&P 900.00% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BMRA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -32.91% | 20.78% |
| Annualized return | -32.91% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BMRA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -94.29% | 83.14% |
| Annualized return | -43.60% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | BMRA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -90.56% | 319.30% |
| Annualized return | -21.02% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |